ANTI-GOR ANTIBODIES IN LICHEN-PLANUS

Anti-GOR antibodies characterize patients with autoimmune hepatitis ty pe 2 who are all positive for antibodies to hepatitis C virus (HCV) an d have low titers of anti-liver/kidney-microsomal (LKM1) antibody. The documented prevalence of anti-HCV antibodies in patients with lichen planus (LP) and chronic liver disease (CLD) and their negativity for a nti-LKM1 antibodies make them eligible for having anti-GOR antibodies. We studied such a possibility in 56 LP patients. Twenty of them had a lso CLD. Seven CLD patients without LP served as control. Overall, 11/ 63 patients had anti-GOR antibodies. Al of them were anti-HCV positive and had CLD. CLD patients with LP showed the same prevalence of anti- GOR antibodies as CLD patients without LP.